{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:44:40Z","timestamp":1782773080579,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH NIAID R01AI16129"],"award-info":[{"award-number":["NIH NIAID R01AI16129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Numerous in vivo studies have demonstrated beta-2-adrenoceptor (\u03b2\n                      <jats:sub>2<\/jats:sub>\n                      AR) -agonism as permissive in the development of allergic lung inflammation, and have implicated the arrestin-dependent signaling arm of the \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      AR in mediating this effect. However, the specific cell type(s) mediating \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      AR regulation of allergic lung inflammation remain unestablished.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To explore the potential contribution of airway epithelia in this phenomenon, we compared the ability of ractopamine (RP), recently identified as a Gs-biased beta-agonist, to that of the unbiased\/balanced beta-agonist albuterol (ALB), on IL-13-stimulated mucin and cytokine production in human airway epithelia cultures in air\u2013liquid interface (HAE). Results: ALB, which activates both the \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      AR-arrestin and -Gs signaling pathways significantly augmented IL-13-induced mucin production in HAE. RP, which preferentially signals via Gs\/PKA, did not. Although IL-13 stimulated production of numerous cytokines, including IL-1\u03b1, IL-1RA, MDC, TGF-\u03b1, and GRO\u03b1, ALB-mediated augmentation of these cytokines was highly variable and not statistically significant. Similarly, RP did not augment the induction of cytokines stimulated by IL-13. Moreover, in contrast to previous studies that reported a requirement of concomitant \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      AR agonism for IL-13 to stimulate cytokine production, such a requirement was observed only in minority of the (12) cultures examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These data implicate arrestin-dependent \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      AR signaling augmenting airway epithelial mucin production as a contributor to the previously-demonstrated pro-inflammatory effects of \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      AR agonism in vivo. Moreover, they suggest that beta-agonist effects on the cytokine profile in the allergen-inflamed lung may be influenced by specific asthmatic endotypes and involve cooperativity among multiple cell types.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03693-4","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:25:19Z","timestamp":1777645519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Qualitative beta-2-adrenoceptor signaling in the regulation of human airway epithelia mucin and cytokine production"],"prefix":"10.1186","volume":"27","author":[{"given":"Fred","family":"Graumuller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung O.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccolette","family":"Schaunaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic R.","family":"Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton F.","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K. L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Wei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond B.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"6","key":"3693_CR1","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jaci.2007.03.022","volume":"119","author":"SP Peters","year":"2007","unstructured":"Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world evaluation of asthma control and treatment (REACT): findings from a national web-based survey. J Allergy Clin Immunol. 2007;119(6):1454\u201361.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3693_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaci.2004.04.042","volume":"114","author":"KF Rabe","year":"2004","unstructured":"Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy ClinImmunol. 2004;114(1):40\u20137.","journal-title":"J Allergy ClinImmunol"},{"issue":"14","key":"3693_CR3","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1073\/pnas.0400452101","volume":"101","author":"Z Callaerts-Vegh","year":"2004","unstructured":"Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF, et al. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A. 2004;101(14):4948\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3693_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1165\/rcmb.2015-0373OC","volume":"55","author":"GS Forkuo","year":"2016","unstructured":"Forkuo GS, Kim H, Thanawala VJ, Al-Sawalha N, Valdez D, Joshi R, et al. PDE4 Inhibitors Attenuate the Asthma Phenotype Produced by beta-adrenoceptor Agonists in PNMT-KO Mice. Am J Respir Cell Mol Biol. 2016;55:234\u201342.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"43","key":"3693_CR5","doi-asserted-by":"publisher","first-page":"E9163","DOI":"10.1073\/pnas.1710196114","volume":"114","author":"LP Nguyen","year":"2017","unstructured":"Nguyen LP, Al-Sawalha NA, Parra S, Pokkunuri I, Omoluabi O, Okulate AA, et al. beta2-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility. Proc Natl Acad Sci U S A. 2017;114(43):E9163\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3693_CR6","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1073\/pnas.0810902106","volume":"106","author":"LP Nguyen","year":"2009","unstructured":"Nguyen LP, Lin R, Parra S, Omoluabi O, Hanania NA, Tuvim MJ, et al. Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A. 2009;106(7):2435\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3693_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1165\/rcmb.2012-0364OC","volume":"48","author":"VJ Thanawala","year":"2013","unstructured":"Thanawala VJ, Forkuo GS, Al-Sawalha N, Azzegagh Z, Nguyen LP, Eriksen JL, et al. beta2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model. Am J Respir Cell Mol Biol. 2013;48(2):220\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"20","key":"3693_CR8","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1111\/bph.13253","volume":"172","author":"VJ Thanawala","year":"2015","unstructured":"Thanawala VJ, Valdez DJ, Joshi R, Forkuo GS, Parra S, Knoll BJ, et al. \u03b2-blockers have differential effects on the murine asthma phenotype. Br J Pharmacol. 2015;172(20):4833\u201346.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"3693_CR9","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1111\/j.1476-5381.2011.01725.x","volume":"165","author":"R Lin","year":"2012","unstructured":"Lin R, Degan S, Theriot BS, Fischer BM, Strachan RT, Liang J, et al. Chronic treatment in vivo with beta-adrenoceptor agonists induces dysfunction of airway beta(2) -adrenoceptors and exacerbates lung inflammation in mice. BrJ Pharmacol. 2012;165(7):2365\u201377.","journal-title":"BrJ Pharmacol"},{"issue":"3","key":"3693_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1165\/rcmb.2009-0198OC","volume":"43","author":"JW Hollingsworth","year":"2010","unstructured":"Hollingsworth JW, Theriot BS, Li Z, Lawson BL, Sunday M, Schwartz DA, et al. Both hematopoietic-derived and non-hematopoietic-derived {beta}-arrestin-2 regulates murine allergic airway disease. Am J Respir Cell Mol Biol. 2010;43(3):269\u201375.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"3693_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1172\/JCI200317265","volume":"112","author":"JK Walker","year":"2003","unstructured":"Walker JK, Fong AM, Lawson BL, Savov JD, Patel DD, Schwartz DA, et al. Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest. 2003;112(4):566\u201374.","journal-title":"J Clin Invest"},{"key":"3693_CR12","doi-asserted-by":"publisher","first-page":"109905","DOI":"10.1016\/j.cellsig.2020.109905","volume":"80","author":"M Ippolito","year":"2021","unstructured":"Ippolito M, Benovic JL. Biased agonism at beta-adrenergic receptors. Cell Signal. 2021;80:109905.","journal-title":"Cell Signal"},{"key":"3693_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2016.04.002","volume":"164","author":"T Pera","year":"2016","unstructured":"Pera T, Penn RB. Bronchoprotection and bronchorelaxation in asthma: new targets, and new ways to target the old ones. Pharmacol Ther. 2016;164:82\u201396.","journal-title":"Pharmacol Ther"},{"issue":"31","key":"3693_CR14","doi-asserted-by":"publisher","first-page":"e2302668120","DOI":"10.1073\/pnas.2302668120","volume":"120","author":"M Ippolito","year":"2023","unstructured":"Ippolito M, De Pascali F, Hopfinger N, Komolov KE, Laurinavichyute D, Reddy PAN, et al. Identification of a beta-arrestin-biased negative allosteric modulator for the beta(2)-adrenergic receptor. Proc Natl Acad Sci U S A. 2023;120(31):e2302668120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"49","key":"3693_CR15","doi-asserted-by":"publisher","first-page":"e2214024119","DOI":"10.1073\/pnas.2214024119","volume":"119","author":"SD Shah","year":"2022","unstructured":"Shah SD, Lind C, De Pascali F, Penn RB, MacKerell AD Jr., Deshpande DA. In silico identification of a beta(2)-adrenoceptor allosteric site that selectively augments canonical beta(2)AR-Gs signaling and function. Proc Natl Acad Sci U S A. 2022;119(49):e2214024119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"3693_CR16","first-page":"e2302668120","volume":"120","author":"F De Pascali","year":"2023","unstructured":"De Pascali F, Ippolito M, Wolfe E, Komolov KE, Hopfinger N, Lemenze D, et al. beta2 -Adrenoceptor agonist profiling reveals biased signalling phenotypes for the beta2 -adrenoceptor with possible implications for the treatment of asthma. Br J Pharmacol. 2023;120(31):e2302668120.","journal-title":"Br J Pharmacol"},{"issue":"15","key":"3693_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1042\/CS20180337","volume":"132","author":"KG Dimasuay","year":"2018","unstructured":"Dimasuay KG, Sanchez A, Schaefer N, Polanco J, Ferrington DA, Chu HW. Immunoproteasomes as a novel antiviral mechanism in rhinovirus-infected airways. Clin Sci (Lond). 2018;132(15):1711\u201323.","journal-title":"Clin Sci (Lond)"},{"key":"3693_CR18","unstructured":"2020 GINA MAIN REPORT 2020 [Available from: https:\/\/ginasthma.org\/gina-reports\/."},{"issue":"2","key":"3693_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1096\/fj.201700555R","volume":"32","author":"T Pera","year":"2018","unstructured":"Pera T, Deshpande DA, Ippolito M, Wang B, Gavrila A, Michael JV, et al. Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines. FASEB J. 2018;32(2):862\u201374.","journal-title":"FASEB J"},{"key":"3693_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1165\/ajrcmb.11.4.7917318","volume":"11","author":"RB Penn","year":"1994","unstructured":"Penn RB, Kelsen SG, Benovic JL. Regulation of b-agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells. Am J Respir Cell Mol Biol. 1994;11:496\u2013505.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"3693_CR21","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1038\/s41467-024-48034-5","volume":"15","author":"JL Everman","year":"2024","unstructured":"Everman JL, Sajuthi SP, Liegeois MA, Jackson ND, Collet EH, Peters MC, et al. A common polymorphism in the Intelectin-1 gene influences mucus plugging in severe asthma. Nat Commun. 2024;15(1):3900.","journal-title":"Nat Commun"},{"issue":"42","key":"3693_CR22","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.1021\/bi051255y","volume":"44","author":"M Guo","year":"2005","unstructured":"Guo M, Pascual RM, Wang S, Fontana MF, Valancius CA, Panettieri RA Jr, et al. Cytokines Regulate beta-2-Adrenergic Receptor Responsiveness in Airway Smooth Muscle via Multiple PKA- and EP2 Receptor-Dependent Mechanisms. Biochemistry. 2005;44(42):13771\u201382.","journal-title":"Biochemistry"},{"issue":"1","key":"3693_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1096\/fj.10-164798","volume":"25","author":"H Yan","year":"2011","unstructured":"Yan H, Deshpande DA, Misior AM, Miles MC, Saxena H, Riemer EC, et al. Anti-mitogenic effects of beta-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J. 2011;25(1):389\u201397.","journal-title":"FASEB J"},{"issue":"8","key":"3693_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1096\/fba.2020-00035","volume":"2","author":"H Danahay","year":"2020","unstructured":"Danahay H, Fox R, Lilley S, Charlton H, Adley K, Christie L, et al. Potentiating TMEM16A does not stimulate airway mucus secretion or bronchial and pulmonary arterial smooth muscle contraction. FASEB Bioadv. 2020;2(8):464\u201377.","journal-title":"FASEB Bioadv"},{"issue":"1","key":"3693_CR25","doi-asserted-by":"publisher","first-page":"L58","DOI":"10.1152\/ajplung.00157.2018","volume":"316","author":"VE Winkelmann","year":"2019","unstructured":"Winkelmann VE, Thompson KE, Neuland K, Jaramillo AM, Fois G, Schmidt H, et al. Inflammation-induced upregulation of P2X(4) expression augments mucin secretion in airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2019;316(1):L58\u201370.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"3693_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.coph.2010.04.009","volume":"10","author":"VE Ortega","year":"2010","unstructured":"Ortega VE, Peters SP. Beta-2 adrenergic agonists: focus on safety and benefits versus risks. Curr Opin Pharmacol. 2010;10(3):246\u201353.","journal-title":"Curr Opin Pharmacol"},{"key":"3693_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1378\/chest.129.1.15","volume":"129","author":"HS Nelson","year":"2006","unstructured":"Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM, Group atSS. The Salmeterol MultiCenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus Salmeterol. Chest. 2006;129:15\u201326.","journal-title":"Chest"},{"key":"3693_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.coph.2014.03.007","volume":"16","author":"JK Walker","year":"2014","unstructured":"Walker JK, DeFea KA. Role for beta-arrestin in mediating paradoxical beta2AR and PAR2 signaling in asthma. Curr Opin Pharmacol. 2014;16:142\u20137.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"3693_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1476-5381.2010.01178.x","volume":"163","author":"JKL Walker","year":"2011","unstructured":"Walker JKL, Penn RB, Hanania NA, Dickey BF, Bond RA. New perspectives regarding \u03b2(2)-adrenoceptor ligands in the treatment of asthma. Br J Pharmacol. 2011;163(1):18\u201328.","journal-title":"Br J Pharmacol"},{"issue":"Suppl 3","key":"3693_CR30","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1513\/AnnalsATS.201807-485AW","volume":"15","author":"EM Dunican","year":"2018","unstructured":"Dunican EM, Watchorn DC, Fahy JV. Autopsy and imaging studies of mucus in asthma. Lessons learned about disease mechanisms and the role of mucus in airflow obstruction. Ann Am Thorac Soc. 2018;15(Suppl 3):S184\u201391.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"3693_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0002-9343(03)00241-9","volume":"115","author":"LM Kuyper","year":"2003","unstructured":"Kuyper LM, Pare PD, Hogg JC, Lambert RK, Ionescu D, Woods R, et al. Characterization of airway plugging in fatal asthma. Am J Med. 2003;115(1):6\u201311.","journal-title":"Am J Med"},{"issue":"2","key":"3693_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jaci.2019.11.031","volume":"145","author":"PG Fallon","year":"2020","unstructured":"Fallon PG, Schwartz C. The high and lows of type 2 asthma and mouse models. J Allergy Clin Immunol. 2020;145(2):496\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"3693_CR33","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nri2870","volume":"10","author":"CM Lloyd","year":"2010","unstructured":"Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol. 2010;10(12):838\u201348.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3693_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.anai.2022.07.027","volume":"129","author":"N Bryant","year":"2022","unstructured":"Bryant N, Muehling LM. T-cell responses in asthma exacerbations. Ann Allergy Asthma Immunol. 2022;129(6):709\u201318.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"3693_CR35","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.4049\/jimmunol.175.6.3746","volume":"175","author":"DA Kuperman","year":"2005","unstructured":"Kuperman DA, Huang X, Nguyenvu L, Holscher C, Brombacher F, Erle DJ. IL-4 receptor signaling in Clara cells is required for allergen-induced mucus production. J Immunol. 2005;175(6):3746\u201352.","journal-title":"J Immunol"},{"issue":"1","key":"3693_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/sj.bjp.0704063","volume":"133","author":"M Laan","year":"2001","unstructured":"Laan M, Lotvall J, Chung KF, Linden A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol. 2001;133(1):200\u20136.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3693_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI0213696","volume":"109","author":"UA Temann","year":"2002","unstructured":"Temann UA, Ray P, Flavell RA. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest. 2002;109(1):29\u201339.","journal-title":"J Clin Invest"},{"issue":"10","key":"3693_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.humimm.2023.06.007","volume":"84","author":"CM Carvajal Gonczi","year":"2023","unstructured":"Carvajal Gonczi CM, Hajiaghayi M, Gholizadeh F, Xavier Soares MA, Touma F, Lopez Naranjo C, et al. The beta2-adrenergic receptor agonist Terbutaline upregulates T helper-17 cells in a protein kinase A-dependent manner. Hum Immunol. 2023;84(10):515\u201324.","journal-title":"Hum Immunol"},{"key":"3693_CR39","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1182\/blood-2005-08-3265","volume":"107","author":"MJ Loza","year":"2006","unstructured":"Loza MJ, Foster S, Peters SP, Penn RB. Beta-agonists modulate T cell functions via direct actions on type 1 and type 2 cells. Blood. 2006;107:2052\u201360.","journal-title":"Blood"},{"issue":"3","key":"3693_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jaci.2007.10.036","volume":"121","author":"MJ Loza","year":"2008","unstructured":"Loza MJ, Foster S, Peters SP, Penn RB. Interactive effects of steroids and beta-agonists on accumulation of type 2 T cells. J Allergy ClinImmunol. 2008;121(3):750\u20135.","journal-title":"J Allergy ClinImmunol"},{"issue":"2","key":"3693_CR41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1006\/cimm.1993.1122","volume":"148","author":"MM Bartik","year":"1993","unstructured":"Bartik MM, Brooks WH, Roszman TL. Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation. Cell Immunol. 1993;148(2):408\u201321.","journal-title":"Cell Immunol"},{"issue":"6","key":"3693_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.bbi.2009.03.003","volume":"23","author":"LH Anane","year":"2009","unstructured":"Anane LH, Edwards KM, Burns VE, Drayson MT, Riddell NE, van Zanten JJ, et al. Mobilization of gammadelta T lymphocytes in response to psychological stress, exercise, and beta-agonist infusion. Brain Behav Immun. 2009;23(6):823\u20139.","journal-title":"Brain Behav Immun"},{"issue":"11","key":"3693_CR43","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/2326-6066.CIR-18-0833","volume":"7","author":"C Daher","year":"2019","unstructured":"Daher C, Vimeux L, Stoeva R, Peranzoni E, Bismuth G, Wieduwild E, et al. Blockade of beta-Adrenergic Receptors Improves CD8(+) T-cell Priming and Cancer Vaccine Efficacy. Cancer Immunol Res. 2019;7(11):1849\u201363.","journal-title":"Cancer Immunol Res"},{"key":"3693_CR44","doi-asserted-by":"publisher","unstructured":"Farooq MA, Ajmal I, Hui X, Chen Y, Ren Y, Jiang W. beta2-Adrenergic Receptor Mediated Inhibition of T Cell Function and Its Implications for CAR-T Cell Therapy. Int J Mol Sci. 2023;24(16):12837. https:\/\/doi.org\/10.3390\/ijms241612837.","DOI":"10.3390\/ijms241612837"},{"issue":"2","key":"3693_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","volume":"26","author":"VM Sanders","year":"2012","unstructured":"Sanders VM. The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain Behav Immun. 2012;26(2):195\u2013200.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"3693_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4168\/aair.2024.16.3.217","volume":"16","author":"DI Suh","year":"2024","unstructured":"Suh DI, Johnston SL. The wiser strategy of using beta-agonists in asthma: mechanisms and rationales. Allergy Asthma Immunol Res. 2024;16(3):217\u201334.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"3693_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","volume":"15","author":"JV Fahy","year":"2015","unstructured":"Fahy JV. Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol. 2015;15(1):57\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3693_CR48","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","volume":"50","author":"BN Lambrecht","year":"2019","unstructured":"Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019;50(4):975\u201391.","journal-title":"Immunity"},{"key":"3693_CR49","doi-asserted-by":"publisher","unstructured":"Venkatesan P. 2025 GINA report for asthma. Lancet Respir Med. 2025;13(7):e49. https:\/\/doi.org\/10.1016\/S2213-2600(25)00242-5.","DOI":"10.1016\/S2213-2600(25)00242-5"},{"issue":"42","key":"3693_CR50","doi-asserted-by":"publisher","first-page":"16657","DOI":"10.1073\/pnas.0707936104","volume":"104","author":"JW Wisler","year":"2007","unstructured":"Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, et al. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci USA. 2007;104(42):16657\u201362.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03693-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03693-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03693-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:01:37Z","timestamp":1782770497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03693-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3693"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03693-4","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies in this manuscript included the use of epithelial cultures derived from human subjects. All subjects underwent informed consent and procedures\/studies were approved by the NJH IRB. Because HAE cultures were generated from banked and deidentified cells, the experiments were judged to be Not Human Subjects Research by TJU, Duke University and NJH IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}